Currently, Wegovy is FDA approved for the following: Children ages 12 years or older with a body mass index (BMI) at or above the 95th percentile for their sex and age Adults with a BMI at or above 30 Adults with a BMI at or above 27 and at least one weight-related health condition, such as heart disease, diabetes, high blood pressure, or sleep apnea Adults with a BMI at or above 27 with established cardiovascular disease and a risk of major adverse cardiovascular events (like heart attack or stroke) Adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis Note that there are slightly different prescribing rules for Wegovy pills versus Wegovy injections
Not the dose escalation, not the dietary changes, but the simple, practical reality of administering an injection to themselves once a week, every week, for months
This helps minimize side effects while still calming mast cell activity and inflammation
Chen, J.-H
Some bioactivity can still be preserved if agitation was brief (under 5 seconds)
L- carnitine injection act as a transporter of long-chain fatty acids into the mitochondria to be oxidized and produce energy